Inventor
FINK BRIAN E
US42 patents
⚠️ This page may combine multiple inventors who share the name “FINK BRIAN E”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
37 patentsUS6916815B2Jul 12, 2005
C-6 modified indazolylpyrrolotriazines
BRISTOL MYERS SQUIBB CO55 citations96
US9273057B2Mar 1, 2016
Imidazotriazinecarbonitriles useful as kinase inhibitors
BRISTOL MYERS SQUIBB CO29 citations93
US7605160B2Oct 20, 2009
Pyrrolotriazine kinase inhibitors
BRISTOL MYERS SQUIBB CO28 citations93
US7148220B2Dec 12, 2006
C-6 modified indazolylpyrrolotriazines
BRISTOL MYERS SQUIBB CO13 citations84
US9273014B2Mar 1, 2016
Bis(fluoroalkyl)-1,4-benzodiazepinone compounds and prodrugs thereof
BRISTOL MYERS SQUIBB CO14 citations83
US8999918B2Apr 7, 2015
Bis(fluoroalkyl)-1,4-benzodiazepinone compounds and prodrugs thereof
BRISTOL MYERS SQUIBB CO9 citations83
US7531539B2May 12, 2009
Pyrrolotriazine kinase inhibitors
BRISTOL MYERS SQUIBB CO18 citations83
US7297695B2Nov 20, 2007
Pyrrolotriazine compounds as kinase inhibitors
BRISTOL MYERS SQUIBB CO9 citations74
US7141571B2Nov 28, 2006
Pyrrolotriazine compounds as kinase inhibitors
BRISTOL MYERS SQUIBB CO8 citations74
US7064203B2Jun 20, 2006
Di-substituted pyrrolotriazine compounds
BRISTOL MYERS SQUIBB CO9 citations74
US11427610B2Aug 30, 2022
Cyclic dinucleotides as anticancer agents
BRISTOL MYERS SQUIBB CO2 citations73
US10953032B2Mar 23, 2021
Cyclic dinucleotides as anticancer agents
BRISTOL MYERS SQUIBB CO2 citations73
US9708316B2Jul 18, 2017
TGFβR antagonists
BRISTOL MYERS SQUIBB CO5 citations72
US9556178B2Jan 31, 2017
Imidazotriazinecarbonitriles useful as kinase inhibitors
BRISTOL MYERS SQUIBB CO3 citations72
US11660311B2May 30, 2023
Cyclic dinucleotides as anticancer agents
BRISTOL MYERS SQUIBB CO2 citations71
US10947263B2Mar 16, 2021
Cyclic dinucleotides as anticancer agents
BRISTOL MYERS SQUIBB CO2 citations71
US9273075B2Mar 1, 2016
Prodrugs of 1,4-benzodiazepinone compounds
BRISTOL MYERS SQUIBB CO4 citations70
US7982033B2Jul 19, 2011
Pyrrolotriazine kinase inhibitors
BRISTOL MYERS SQUIBB CO2 citations63
US7846931B2Dec 7, 2010
Pyrrolotriazine compounds as kinase inhibitors
BRISTOL MYERS SQUIBB CO1 citations63
US7776859B2Aug 17, 2010
Hexahydroimidazopyrazin-3-one compounds useful as modulators of androgen receptor function
BRISTOL MYERS SQUIBB CO2 citations63
US7514435B2Apr 7, 2009
Pyrrolotriazine kinase inhibitors
BRISTOL MYERS SQUIBB CO3 citations63
US7417040B2Aug 26, 2008
Fused tricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3
BRISTOL MYERS SQUIBB CO3 citations63
US7378426B2May 27, 2008
Fused heterotricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3
BRISTOL MYERS SQUIBB CO2 citations63
US12012374B2Jun 18, 2024
Agonists of ROR GAMMAt
BRISTOL MYERS SQUIBB CO0 citations62
US9133139B2Sep 15, 2015
Fluoroalkyl-1,4-benzodiazepinone compounds
BRISTOL MYERS SQUIBB CO2 citations62
US8940736B2Jan 27, 2015
Imidazotriazinecarbonitriles useful as kinase inhibitors
BRISTOL MYERS SQUIBB CO3 citations62
US11339185B2May 24, 2022
Cyclic dinucleotides as anticancer agents
BRISTOL MYERS SQUIBB CO0 citations60
US10336761B2Jul 2, 2019
TGFβ receptor antagonist
BRISTOL MYERS SQUIBB CO1 citations60
US10292985B2May 21, 2019
TGF beta receptor antagonists
BRISTOL MYERS SQUIBB CO1 citations58
US9427442B2Aug 30, 2016
Fluoroalkyl and fluorocycloalkyl 1,4-benzodiazepinone compounds
BRISTOL MYERS SQUIBB CO0 citations52
US7569725B2Aug 4, 2009
Anthranilic acid derivatives as inhibitors of 17β-hydroxysteroid dehydrogenase 3
BRISTOL MYERS SQUIBB CO0 citations52
US11945834B2Apr 2, 2024
Cyclic dinucleotides as anticancer agents
BRISTOL MYERS SQUIBB CO0 citations51
US10519187B2Dec 31, 2019
Cyclic dinucleotides as anticancer agents
BRISTOL MYERS SQUIBB CO0 citations50
US9371328B2Jun 21, 2016
Imidazopyridazinecarbonitriles useful as kinase inhibitors
BRISTOL MYERS SQUIBB CO0 citations50
US9242941B2Jan 26, 2016
Alkyl, fluoroalkyl-1,4-benzodiazepinone compounds
BRISTOL MYERS SQUIBB CO0 citations41
US10744150B2Aug 18, 2020
Cyclic dinucleotides as anticancer agents
BRISTOL MYERS SQUIBB CO0 citations40
US10399987B2Sep 3, 2019
TGF beta receptor antagonists
BRISTOL MYERS SQUIBB CO0 citations37
FINK BRIAN E
4 patentsUS8252795B2Aug 28, 2012
Imidazopyridazinecarbonitriles useful as kinase inhibitors
FINK BRIAN E19 citations89
US8148523B2Apr 3, 2012
Intermediates useful in preparing certain pyrrolotriazine compounds and a process for making the intermediates
FINK BRIAN E0 citations51
US8389527B2Mar 5, 2013
Substituted imidazopyridazines useful as kinase inhibitors
FINK BRIAN E1 citations48
US8268998B2Sep 18, 2012
Pyrrolotriazine kinase inhibitors
FINK BRIAN E0 citations40